Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications
Regenerative Therapy · 2026-12 · 33 · 101172
DOI: 10.1016/j.reth.2026.101172 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Therapy, 2026-12. Verfasst von Jason K M Choi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. Die Arbeit nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Japan Agency for Medical Research and Development.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.
Förderung
- Japan Society for the Promotion of Science
- Japan Science and Technology Agency
- Japan Agency for Medical Research and Development
Zitieren
APA
Choi, J. K. M., & Hotta, A. (2026). Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications. Regenerative Therapy, 33, 101172. https://doi.org/10.1016/j.reth.2026.101172
Vancouver
Choi JKM, Hotta A. Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications. Regenerative Therapy. 2026;33:101172. doi:10.1016/j.reth.2026.101172
BibTeX
@article{Choi2026,
author = {Choi, Jason K M and Hotta, Akitsu},
title = {Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications},
journal = {Regenerative Therapy},
year = {2026},
volume = {33},
pages = {101172},
doi = {10.1016/j.reth.2026.101172}
}
EUVIMED